Sab Biotherapeutics Inc. (SABS)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
3. 54
-0.12
-3.4106%
$
34.41M Market Cap
0.1 P/E Ratio
- Div Yield
678,400 Volume
0 Eps
$ 3.67
Previous Close 
Want to track SABS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sab Biotherapeutics Inc. (SABS) Statistics
Valuation metrics
Market Cap 34.41M
Enterprise value 19.49M
Trailing P/E (ttm) 8.23
Forward P/E -
PEG ratio -0.25
Price/Sales (ttm) -
Price/Book (mrq) 0.83
Enterprise Value/Revenue -
Enterprise Value/EBITDA 6.63
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 677.62K
Average volume (90 days) 1.24M
Price summary
52-Week low 1.85
52-Week high 6.6
Beta -
50-Day moving average 3.69
200-Day moving average 3.89
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 5 Jan 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0%
Return on equity -0%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.01
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.01
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 11.45%
Book value per share (mrq) 4.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
